Literature DB >> 10974462

Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results.

M P Sunyach1, L Falchero, P Pommier, M Perol, D Arpin, M Vincent, D Boutry, P Rebatu, C Ginestet, I Martel-Lafay, D Perol, C Carrie.   

Abstract

PURPOSE: Radiation pneumonitis is the restricting complication following lung cancer irradiation. The correlation between dose-volume histograms (DVHs) and pneumonitis, with a clinical, radiological, and respiratory function evaluation was assessed. Special endpoint was the evaluation of respiratory function after three-dimensional conformal radiotherapy (3D-CRT). METHODS AND MATERIALS: Fifty-four patients with non metastatic non-small-cell lung cancer (NSCLC) were treated with a curative intent with 3D-CRT (66 Gy). Thirty-one patients were treated postoperatively (pneumonectomy in 9 patients) for residual tumor or massive nodal involvement (N2 or N3); 23 patients were treated with exclusive radiotherapy. Clinical evaluation, CT scan, and pulmonary functional tests were performed before and 6 weeks after irradiation. The DVHs were calculated applying lung density heterogeneity.
RESULTS: Twenty patients had radiation pneumonitis. Irradiation significantly decreased total lung capacity. Volume of the PTV2 (more than 200 cm(3)) was a significant prognostic factor for lung complication.
CONCLUSION: DVHs combined with initial pulmonary functional tests can predict pulmonary toxicity and could allow us to adjust volume that received total highest dose with acceptable toxicity.

Entities:  

Mesh:

Year:  2000        PMID: 10974462     DOI: 10.1016/s0360-3016(00)00618-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Heart irradiation as a risk factor for radiation pneumonitis.

Authors:  Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley
Journal:  Acta Oncol       Date:  2010-09-28       Impact factor: 4.089

2.  Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation.

Authors:  Isis W Gayed; Joe Chang; E Edmund Kim; Rodolfo Nuñez; Beth Chasen; H Helen Liu; Katsuhiro Kobayashi; Yujing Zhang; Zhongxing Liao; Salman Gohar; Melinda Jeter; Louise Henderson; William Erwin; Ritsuko Komaki
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

3.  Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity.

Authors:  Martin Turzer; Odd Terje Brustugun; Einar Waldeland; Aslaug Helland
Journal:  Case Rep Oncol       Date:  2011-01-21

4.  The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancer.

Authors:  Michał Spych; Leszek Gottwald; Małgorzata Klonowicz; Michał Biegała; Robert Bibik; Jacek Fijuth
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

Review 5.  The role of PDGF in radiation oncology.

Authors:  Minglun Li; Verena Jendrossek; Claus Belka
Journal:  Radiat Oncol       Date:  2007-01-11       Impact factor: 3.481

6.  Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.

Authors:  Kazuhiko Hayashi; Naoyoshi Yamamoto; Masataka Karube; Mio Nakajima; Naruhiro Matsufuji; Hiroshi Tsuji; Kazuhiko Ogawa; Tadashi Kamada
Journal:  Radiat Oncol       Date:  2017-05-30       Impact factor: 3.481

7.  Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.

Authors:  Jun Dang; Guang Li; Shuang Zang; Shuo Zhang; Lei Yao
Journal:  Radiat Oncol       Date:  2014-07-30       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.